Luther King Capital Management (LKCM)
EVFM

Luther King Capital Management (LKCM)’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,000
Closed -$100K – 554
2019
Q2 		$100K Buy
+1,000
New +$77.5K ﹤0.01% 521

Other funds holding EVFM

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Luther King Capital Management (LKCM)'s EVFM Position: Q3 2019 in Review

Luther King Capital Management (LKCM) sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2019, closing a stake of 1,000 shares — an estimated $100K sold.

Luther King Capital Management (LKCM) first reported a position in EVFM in Q2 2019 and held it in 1 quarter. The position peaked at $100K in Q2 2019. 42 funds tracked by Wall St. Rank hold EVFM as of Q3 2019.

  • Luther King Capital Management (LKCM) reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 1,000 Evofem Biosciences, Inc. Common Stock shares in Q3 2019, an estimated $100K.
  • Luther King Capital Management (LKCM) first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Luther King Capital Management (LKCM)'s Evofem Biosciences, Inc. Common Stock position peaked at $100K in Q2 2019.
  • 42 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2019.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q3 2019, filed 12 Nov 2019.